Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,678.00    20.00 (1.21%)
Bid:
1,676.00
Ask:
1,680.00
Spread: 4.00 (0.239%)
Market Cap: £494.20m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

Interim Management Statement

7 Feb 2013 07:00

RNS Number : 3162X
Avon Rubber PLC
06 February 2013
 



Strictly embargoed until 07:00 Thursday 7 February 2013

 

AVON RUBBER p.l.c. ("Avon", the "Group" or the "Company")

INTERIM MANAGEMENT STATEMENT FOR THE PERIOD FROM 1 OCTOBER 2012 TO 6 FEBRUARY 2013

 

Introduction

The financial year has started positively and the investments we have made and continue to make in innovative new products and to gain access to new markets have positioned us well to deliver further growth this year.

 

Protection & Defence

In Protection & Defence an improved order book was carried forward into this financial year and included the £14.7m Middle Eastern order announced in May 2012. This has resulted in a stronger first quarter performance compared to the previous year.

 

We have delivered M50 mask systems to the US Department of Defense (DoD) at a similar rate to 2012 and, despite continued uncertainty, we believe that we are well positioned and should not be significantly impacted by US Government cuts in the defence budget. We already have orders in hand for mask systems through to the end of our third quarter. As expected, we delivered 130,000 pairs of M61 filters during the period. We also secured orders for a further 100,000 pairs which we expect to deliver in our second quarter. So far sales to the US homeland security and first responder markets have been significantly stronger than in 2012.

 

Our first new product under Project Fusion was launched during the quarter. The PC50 is an air purifying respirator targeted specifically at the US correctional facilities market. Project Fusion as a whole, which is expected to deliver further organic growth from 2014, remains on track.

 

Dairy

The Milkrite ImpulseAir mouthpiece vented liner continues to perform well and we have seen further quarter on quarter sales growth at our newly established Chinese operation.

 

In other markets lower milk prices and higher feed costs in our traditional markets have reduced farmer revenues and margins, leading to fluctuating demand for our consumable products in the first quarter of our financial year. Planned new product introductions should provide opportunities for growth in the remainder of the year.

 

 

Net debt

The Group's balance sheet remains robust with net debt at 31 December 2012 at £10.1m (30 September 2012: £8.7m) due to the timing of working capital movements and the £1.8m of funding provided to the Employee Share Ownership Trusts to fund the purchase of the Company's shares for awards under the Performance Share Plan. 

 

 

Board changes

As previously announced Sir Richard Needham will retire as a Director at the conclusion of today's Annual General Meeting.

 

Outlook

Given the positive start to the year, the Board is confident of meeting full year market expectations, despite the challenges provided by the uncertain economic and political environment, particularly in the US.

 

Half Year announcement

The Group will announce its results for the half year to 31 March 2013 on Wednesday 1st May 2013.

 

For further enquiries, please contact:

 

 

Avon Rubber p.l.c.

Peter Slabbert, Chief Executive

01225 896831

Andrew Lewis, Group Finance Director

01225 896830

Miles Ingrey-Counter, Company Secretary

01225 896850

Sarah Matthews-DeMers, Group Financial Controller

01225 896835

Weber Shandwick Financial

Nick Oborne

020 7067 0700

Stephanie Badjonat

020 7067 0700

 

 

 

 

 

 

NOTES TO EDITORS: Avon is focused on two specialist areas - Protection & Defence and Dairy

With over 120 years' experience, Avon Rubber p.l.c. is an innovative design and engineering group specialising in two core markets, Protection & Defence and Dairy. With a strong emphasis on research and development, we design, test and manufacture specialist products from a number of sites in the US and the UK, serving markets around the world.

Avon Protection is the recognised global market leader in advanced Chemical, Biological, Radiological and Nuclear (CBRN) respiratory protection system technology. Our unrivalled 80 year pedigree in military mask design and manufacture has placed Avon Protection's products at the heart of many international defence and tactical Personal Protective Equipment (PPE) deployment strategies. Our expanding global customer base now includes military forces, civil and first line defence troops, emergency service teams and industrial, marine, mineral and oil extraction site personnel. All put their trust in Avon's advanced respiratory solutions.

Our world leading Dairy business and its Milkrite brand have a global market presence. Our unique designs and innovative technology are described by one particular customer as "the biggest advance in the milking process in a generation". Working with the leading scientists and health specialists in the industry, we continue to invest in technology to further improve the milking process and animal welfare. As our market share and milking experience continues to grow so does our global presence.

For further information please visit the Group's website www.avon-rubber.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSSSFFAMFDSESE
Date   Source Headline
13th May 20267:00 amRNSInterim Results
8th May 20267:00 amRNSHolding(s) in Company
6th May 20262:03 pmRNSDirector/PDMR Shareholding
28th Apr 20267:00 amRNSHolding(s) in Company
14th Apr 20267:00 amRNSNotice of Results and Investor Presentation
8th Apr 202612:15 pmRNSHolding(s) in Company
8th Apr 202611:47 amRNSDirector/PDMR Shareholding
27th Mar 20261:23 pmRNSDirector/PDMR Shareholding
6th Mar 20261:23 pmRNSDirectors'/PDMR Shareholdings
6th Mar 20267:00 amRNSNew Filter Order
3rd Mar 20262:34 pmRNSHolding(s) in Company
13th Feb 202611:01 amRNSDirector/PDMR Shareholding
6th Feb 20262:52 pmRNSDirectors'/PDMR Shareholdings
6th Feb 20262:41 pmRNSFinal Dividend Currency Exchange Rate
4th Feb 20264:18 pmRNSHolding(s) in Company
2nd Feb 202610:10 amRNSResult of AGM
30th Jan 20267:00 amRNSAGM & Q1 Trading Update
20th Jan 20263:19 pmRNSDirector/PDMR Shareholding
6th Jan 20261:46 pmRNSDirectors'/PDMR Shareholdings
23rd Dec 20259:21 amRNSDirector/PDMR Shareholding
23rd Dec 20259:21 amRNSDirector/PDMR Shareholding
16th Dec 20258:45 amRNSHolding(s) in Company
11th Dec 20253:51 pmRNSHolding(s) in Company
11th Dec 20257:00 amRNSEuropean FM50 Order
9th Dec 202511:58 amRNSDirectors'/PDMR Shareholding
8th Dec 20251:32 pmRNSDirectors'/PDMR Shareholdings
5th Dec 20259:00 amRNSNotice of Annual Report & Accounts and AGM 2026
1st Dec 20256:01 pmRNSDirector Declaration
25th Nov 20253:55 pmRNSHolding(s) in Company
21st Nov 20259:50 amRNSNotification of LTIP & DSBP Awards
12th Nov 20257:00 amRNSPreliminary Results
7th Nov 20259:23 amRNSDirectors'/PDMR Shareholdings
16th Oct 20257:00 amRNSNotice of Results & Investor Presentation via IMC
8th Oct 202510:06 amRNSDirectors'/PDMR Shareholding
15th Sep 20252:51 pmRNSHolding(s) in Company
11th Sep 20254:10 pmRNSHolding(s) in Company
8th Sep 20251:14 pmRNSDirectors'/PDMR Shareholding
13th Aug 20254:59 pmRNSInterim Dividend Currency Exchange Rate
11th Aug 20254:47 pmRNSHolding(s) in Company
7th Aug 20253:10 pmRNSDirectors'/PDMR Shareholdings
17th Jul 20257:00 amRNSDirectors'/PDMR Shareholdings
23rd Jun 20257:00 amRNSUK MoD respirator order for Ukraine
10th Jun 20257:00 amRNSHolding(s) in Company
9th Jun 20259:30 amRNSDirectors'/PDMR Shareholdings
5th Jun 20253:31 pmRNSUS Department of Defense Order
3rd Jun 20256:00 pmRNSRenewi
29th May 202510:00 amRNSHolding(s) in Company
21st May 20257:00 amRNSInterim Results
20th May 20254:00 pmRNSNotification of change in particulars of director
16th May 20253:00 pmRNSNotification of change in particulars of director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.